Clinicopathological stratification of myeloid sarcoma: Differences between acute leukemia-associated, chronic myeloid neoplasm-associated, and de novo disease - A single-center study of 126 cases.
Categorizing myeloid sarcoma into distinct subtypes reveals different prognosis and treatment implications, refining management strategies.
Clinicopathological analysis of 126 myeloid sarcoma cases revealed distinct biological and prognostic differences between acute leukemia-associated, chronic myeloid neoplasm-associated, and de novo disease categories. This stratification identifies clinically meaningful subgroups with different management implications.
What the study was
- Study design
- single_center_retrospective_cohort
- Category
- hematologic_malignancies
- Maturity
- Validated
Why it surfaced
Large single-center stratification study of a rare and heterogeneous hematologic malignancy. Relevant to hematologic malignancies watchlist. Myeloid sarcoma lacks large systematic studies; this 126-case analysis provides meaningful epidemiological and clinical data.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.